Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum

Abstract Background Multimer detection system-oligomeric amyloid-β (MDS-OAβ) is a measure of plasma OAβ, which is associated with Alzheimer’s disease (AD) pathology. However, the relationship between MDS-OAβ and disease severity of AD is not clear. We aimed to investigate MDS-OAβ levels in different...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Sheng-Min Wang, Dong Woo Kang, Yoo Hyun Um, Sunghwan Kim, Chang Uk Lee, Philip Scheltens, Hyun Kook Lim
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	BMC 2024-03-01
سلاسل:	Alzheimer’s Research & Therapy
الموضوعات:	Oligomerization Blood-based biomarker Beta amyloid Mild cognitive impairment Dementia And Alzheimer’s disease
الوصول للمادة أونلاين:	https://doi.org/10.1186/s13195-024-01400-3
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!